Devdiscourse

Global HIV Care Gets a Reset as WHO Issues New Rules on Treatment, Infants and TB

WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...
9NEWS

Denver medical professional hopes new guidelines will expand access to HIV drug

DENVER — For the first time in nearly 10 years, the World Health Organization (WHO) will update its guidelines on the usage of post-exposure prophylaxis (PEP), which is a medication that can be taken ...
Mid-Day

WHO strongly recommends CD4 testing to identify advanced HIV disease

At presentation, all children living with HIV younger than five years should be considered as having advanced HIV disease ...

Some patients face hurdles getting HIV prevention drugs. Here's what to know

A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.

Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial

Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment responses of adults with HIV who are ...

Advanced white blood cell testing to identify HIV disease strongly recommended by WHO

CD4 tests is strongly recommended as the preferred method to identify advanced HIV disease among people living with HIV, said ...
The Providence Journal

RI is close to eliminating new HIV infections. Why an insurer's decision could change that

PROVIDENCE – Infectious disease doctors and public health advocates are raising concerns as Harvard Pilgrim, a health insurance provider, plans to phase out coverage of several HIV treatments next ...